Loading clinical trials...
Loading clinical trials...
This is an 8-week, multicenter, randomized, double blind, placebo controlled study to evaluate the efficacy and safety of aripiprazole as an adjunctive treatment with mood stabilizer for the treatment...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Korea Otsuka Pharmaceutical Co., Ltd.
NCT02827045 · Bipolar Disorder, Depression, Bipolar
NCT04640636 · Depression, Unipolar, Depression, Bipolar, and more
NCT06105762 · Depressive Disorder, Major Depressive Disorder, and more
NCT04846010 · Sequelae of; Infection, Post Infection Glomerulonephritis, and more
NCT00483548 · Bipolar Disorder, Depression, Bipolar
Seounl National University Hospital
Seoul
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions